PRC2 Inhibitors Overcome Glucocorticoid Resistance Driven by <i>NSD2</i> Mutation in Pediatric Acute Lymphoblastic Leukemia

Jianping Li, Julia Hlavka-Zhang, Jonathan H. Shrimp, Crissandra Piper, Daphne Dupéré-Richér, Jacob S. Roth, Duohui Jing, Heidi L. Casellas Román, Catalina Troche, Alok Swaroop, Marta Kulis, Jon A. Oyer, Christine M. Will, Min Shen, Alberto Riva, Richard L. Bennett, Adolfo A. Ferrando, Matthew D. Hall, Richard B. Lock, Jonathan D. Licht

Open source

DOI
10.1158/2159-8290.cd-20-1771
Published
2022-01-01
Container
Cancer Discovery
Publisher
American Association for Cancer Research (AACR)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1158/2159-8290.cd-20-1771,
  title = {PRC2 Inhibitors Overcome Glucocorticoid Resistance Driven by
                    <i>NSD2</i>
                    Mutation in Pediatric Acute Lymphoblastic Leukemia},
  author = {Jianping Li and Julia Hlavka-Zhang and Jonathan H. Shrimp and Crissandra Piper and Daphne Dupéré-Richér and Jacob S. Roth and Duohui Jing and Heidi L. Casellas Román and Catalina Troche and Alok Swaroop and Marta Kulis and Jon A. Oyer and Christine M. Will and Min Shen and Alberto Riva and Richard L. Bennett and Adolfo A. Ferrando and Matthew D. Hall and Richard B. Lock and Jonathan D. Licht},
  year = {2022},
  journal = {Cancer Discovery},
  doi = {10.1158/2159-8290.cd-20-1771},
  url = {https://doi.org/10.1158/2159-8290.cd-20-1771}
}

RIS

TY  - JOUR
TI  - PRC2 Inhibitors Overcome Glucocorticoid Resistance Driven by
                    <i>NSD2</i>
                    Mutation in Pediatric Acute Lymphoblastic Leukemia
AU  - Jianping Li
AU  - Julia Hlavka-Zhang
AU  - Jonathan H. Shrimp
AU  - Crissandra Piper
AU  - Daphne Dupéré-Richér
AU  - Jacob S. Roth
AU  - Duohui Jing
AU  - Heidi L. Casellas Román
AU  - Catalina Troche
AU  - Alok Swaroop
AU  - Marta Kulis
AU  - Jon A. Oyer
AU  - Christine M. Will
AU  - Min Shen
AU  - Alberto Riva
AU  - Richard L. Bennett
AU  - Adolfo A. Ferrando
AU  - Matthew D. Hall
AU  - Richard B. Lock
AU  - Jonathan D. Licht
PY  - 2022
JO  - Cancer Discovery
DO  - 10.1158/2159-8290.cd-20-1771
UR  - https://doi.org/10.1158/2159-8290.cd-20-1771
ER  - 

APA

Li, J., Hlavka-Zhang, J., Shrimp, J. H., Piper, C., Dupéré-Richér, D., Roth, J. S., Jing, D., Román, H. L. C., Troche, C., Swaroop, A., Kulis, M., Oyer, J. A., Will, C. M., Shen, M., Riva, A., Bennett, R. L., Ferrando, A. A., Hall, M. D., Lock, R. B., & Licht, J. D. (2022). PRC2 Inhibitors Overcome Glucocorticoid Resistance Driven by <i>NSD2</i> Mutation in Pediatric Acute Lymphoblastic Leukemia. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-20-1771

Source records